Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3282)
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
15,000
Price
$134.49
Total Value
$2.02M
Shares Held After
59,375
% of Holdings
20.2%
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
19,836
Price
$134.49
Total Value
$2.67M
Shares Held After
74,375
% of Holdings
21.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
919
Price
$33.15
Total Value
$30.46K
Shares Held After
3,613,123
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,545
Price
$32.16
Total Value
$950.04K
Shares Held After
3,614,042
% of Holdings
0.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
1,439
Price
$33.16
Total Value
$47.71K
Shares Held After
3,613,056
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,025
Price
$32.13
Total Value
$932.55K
Shares Held After
3,614,495
% of Holdings
0.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
11
Price
$33.34
Total Value
$366.74
Shares Held After
190,838
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
9,525
Price
$32.46
Total Value
$309.14K
Shares Held After
190,849
% of Holdings
4.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
2,081
Price
$33.09
Total Value
$68.86K
Shares Held After
278,064
% of Holdings
0.7%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
7,947
Price
$32.21
Total Value
$256.00K
Shares Held After
280,145
% of Holdings
2.8%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
1,042
Price
$33.23
Total Value
$34.63K
Shares Held After
233,625
% of Holdings
0.4%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
9,768
Price
$32.27
Total Value
$315.19K
Shares Held After
234,667
% of Holdings
4.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,000
Price
$38.30
Total Value
$1.15M
Shares Held After
56,450
% of Holdings
34.7%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
10,000
Price
$2.73
Total Value
$27.30K
Shares Held After
996,967
% of Holdings
1.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,000
Price
$2.75
Total Value
$8.25K
Shares Held After
665,000
% of Holdings
0.5%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
37,595
Price
$1.32
Total Value
$49.52K
Shares Held After
773,296
% of Holdings
4.9%
Dominari Holdings Inc. (DOMH)
Hayes Anthony — Director
Shares
50,000
Price
$2.02
Total Value
$101.06K
Shares Held After
4,550,873
% of Holdings
1.1%
Dominari Holdings Inc. (DOMH)
Wool Kyle Michael — Director
Shares
50,000
Price
$2.02
Total Value
$101.06K
Shares Held After
4,261,828
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,412
Price
$107.58
Total Value
$582.23K
Shares Held After
767,780
% of Holdings
0.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
14,588
Price
$107.01
Total Value
$1.56M
Shares Held After
773,192
% of Holdings
1.9%
Aardvark Therapeutics, Inc. (AARD)
Sun Nelson — Chief Financial&Operating Officer
Shares
14,754
Price
$5.00
Total Value
$73.78K
Shares Held After
97,475
% of Holdings
13.1%
Candel Therapeutics, Inc. (CADL)
Tak Paul Peter — Director
Shares
220,866
Price
$11.50
Total Value
$2.54M
Shares Held After
172,700
% of Holdings
56.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
10,000
Price
$67.34
Total Value
$673.40K
Shares Held After
1,316,594
% of Holdings
0.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
20,500
Price
$96.31
Total Value
$1.97M
Shares Held After
688,209
% of Holdings
2.9%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
10,185
Price
$17.62
Total Value
$179.46K
Shares Held After
39,900
% of Holdings
20.3%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
3,100
Price
$68.09
Total Value
$211.07K
Shares Held After
91,500
% of Holdings
3.3%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
14,000
Price
$67.46
Total Value
$944.49K
Shares Held After
94,600
% of Holdings
12.9%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
1,200
Price
$66.15
Total Value
$79.38K
Shares Held After
108,600
% of Holdings
1.1%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
1,700
Price
$65.39
Total Value
$111.17K
Shares Held After
109,800
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$508.80
Total Value
$142.47K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$506.76
Total Value
$141.89K
Shares Held After
324,723
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$505.94
Total Value
$303.56K
Shares Held After
325,003
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
702
Price
$505.03
Total Value
$354.53K
Shares Held After
325,603
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$503.76
Total Value
$291.17K
Shares Held After
326,305
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$502.80
Total Value
$772.30K
Shares Held After
326,883
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,244
Price
$501.88
Total Value
$1.13M
Shares Held After
328,419
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,372
Price
$500.58
Total Value
$686.80K
Shares Held After
330,663
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,788
Price
$499.75
Total Value
$893.55K
Shares Held After
332,035
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$498.44
Total Value
$59.81K
Shares Held After
333,823
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
Robertson Stephen P. — Chief Legal Officer
Shares
11,939
Price
$15.95
Total Value
$190.43K
Shares Held After
588,848
% of Holdings
2.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$2.76
Total Value
$13.80K
Shares Held After
662,000
% of Holdings
0.8%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.10
Total Value
$410.00K
Shares Held After
1,500,000
% of Holdings
6.7%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
79,800
Price
$4.25
Total Value
$339.15K
Shares Held After
1,000,000
% of Holdings
8.0%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
7,278
Price
$144.10
Total Value
$1.05M
Shares Held After
522,968
% of Holdings
1.4%
Lyell Immunopharma, Inc. (LYEL)
Shook David — Chief Medical Officer
Shares
500
Price
$12.70
Total Value
$6.35K
Shares Held After
20,423
% of Holdings
2.4%
Ocugen, Inc. (OCGN)
Musunuri Shankar — Director
Shares
57,264
Price
$1.12
Total Value
$64.14K
Shares Held After
1,088,035
% of Holdings
5.0%
Ocugen, Inc. (OCGN)
Musunuri Shankar — Director
Shares
468,727
Price
$1.12
Total Value
$524.97K
Shares Held After
4,487,197
% of Holdings
9.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$108.67
Total Value
$10.87K
Shares Held After
767,780
% of Holdings
0.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,596
Price
$107.82
Total Value
$711.19K
Shares Held After
767,880
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,304
Price
$107.22
Total Value
$1.43M
Shares Held After
774,476
% of Holdings
1.7%
Showing 351–400 of 3282 transactions (page 8 of 66)